OXYGENTA PHARMACEUTICAL
Back to Balance Sheet
|
OXYGENTA PHARMACEUTICAL Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12 Cr | ₹41 Cr | ₹68 Cr | ₹58 Cr | ₹54 Cr |
What is the latest Total Non-Current Liabilities ratio of OXYGENTA PHARMACEUTICAL ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹41 Cr |
| Mar2023 | ₹68 Cr |
| Mar2022 | ₹58 Cr |
| Mar2021 | ₹54 Cr |
How is Total Non-Current Liabilities of OXYGENTA PHARMACEUTICAL Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹12 Cr | -71.15 | |
| Mar2024 | ₹41 Cr | -39.49 | |
| Mar2023 | ₹68 Cr | 17.02 | |
| Mar2022 | ₹58 Cr | 6.16 | |
| Mar2021 | ₹54 Cr | - | |
Compare Total Non-Current Liabilities of peers of OXYGENTA PHARMACEUTICAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| OXYGENTA PHARMACEUTICAL | ₹214.6 Cr | -0.9% | 3% | -32.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹411,402.0 Cr | 1.2% | -0.9% | -1.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹164,277.0 Cr | 2.7% | -3.8% | 5.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹138,140.0 Cr | 2.1% | 2.8% | 30.9% | Stock Analytics | |
| CIPLA | ₹107,398.0 Cr | -0.1% | -8.2% | -8.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,378.0 Cr | 2.7% | 7.1% | 2.8% | Stock Analytics | |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| OXYGENTA PHARMACEUTICAL | -0.9% |
3% |
-32.3% |
| SENSEX | 0.4% |
-0.2% |
6.9% |
You may also like the below Video Courses